for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

MEIJI Holdings Co Ltd

2269.T

Latest Trade

7,770.00JPY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

7,200.00

 - 

9,240.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7,770.00
Open
--
Volume
--
3M AVG Volume
6.71
Today's High
--
Today's Low
--
52 Week High
9,240.00
52 Week Low
7,200.00
Shares Out (MIL)
145.07
Market Cap (MIL)
1,207,726.00
Forward P/E
17.18
Dividend (Yield %)
1.83

Next Event

Q3 2020 Meiji Holdings Co Ltd Earnings Release

Latest Developments

More

Meiji Holdings and unit to acquire stake for 18 bln yen

Kotobuki Spirits to buy Japan-based company from subsidiary of Meiji Holdings

Meiji Holdings announces drink type production capacity improvement of subsidiary

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About MEIJI Holdings Co Ltd

MEIJI Holdings Co., Ltd. is a Japan-based holding company engaged in the management of subsidiaries that manufactures and sells food and medicines. The Company operates its business through two business segments. The Food segment is involved in the manufacture and sale of yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, frozen food, chocolate, gummi, gum, sports nutrition, powdered milk, liquid food, beauty food, general medicine, sugar, saccharified flour and others. The Pharmaceuticals segment is involved in the manufacture and sale of ethical pharmaceuticals, agricultural chemicals and animal drugs.

Industry

Food Processing

Contact Info

2-4-16, Kyobashi

+81.3.32734001

https://www.meiji.com/

Executive Leadership

Masahiko Matsuo

Chairman of the Board, Chairman of Subsidiaries, Representative Director

Kazuo Kawamura

President, Representative Director

Koichiro Shiozaki

Managing Executive Officer, Director of Accounting & Finance, Director

Daikichiro Kobayashi

President of Subsidiary, Director

Katsunari Matsuda

President of Subsidiary, Director

Key Stats

2.78 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

1.2K

2018

1.2K

2019

1.3K

2020(E)

1.3K
EPS (JPY)

2017

413.110

2018

422.150

2019

426.610

2020(E)

460.350
Price To Earnings (TTM)
20.70
Price To Sales (TTM)
0.96
Price To Book (MRQ)
2.10
Price To Cash Flow (TTM)
11.71
Total Debt To Equity (MRQ)
23.47
LT Debt To Equity (MRQ)
14.34
Return on Investment (TTM)
8.39
Return on Equity (TTM)
5.74

Latest News

Latest News

BRIEF-Meiji Holdings and unit to acquire stake for 18 bln yen

* Says co and unit Meiji Seika Pharma Co Ltd plan to acquire 49 percent stake in a succession company of The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), for 18 billion yen in total

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up